definiens: within the meaningof the Private Securities Litigation Reform Act of 1995 . Because such statements are subject to risks and uncertainties, actual results maydiffer materially from those expressed or implied by such forward - looking statements . Such statements include, but are not limited to, statements regarding : [COMPANY] ’s expectations regarding the potential benefits of AIMab7195 ; and [COMPANY] ’s expectations regardingpotential applications of the CODIT ™ approach to treating life - threatening food allergies . Risks and uncertainties that contribute to theuncertain nature of the forward - looking statements include : the expectation that [COMPANY] will need additional funds to finance its operations;Aimmune ’s dependence on the success of PALFORZIA ; [COMPANY] ’s reliance on third parties for the manufacture of AIMab7195,PALFORZIA and other product candidates ; possible regulatory developments in the United States and foreign countries ; and Aimmune’sability to attract and retain senior management personnel . These and other risks and uncertainties are described more fully in Aimmune’smost recent filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10 - Q for the quarter endedSeptember 30, 2019 . All forward - looking statements contained in this press release speak only as of the date on which they were made